Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

134.53
-6.4500-4.58%
Post-market: 135.751.22+0.91%19:59 EDT
Volume:170.28K
Turnover:24.09M
Market Cap:26.91M
PE:- -
High:151.32
Open:130.36
Low:130.36
Close:140.98
52wk High:165.00
52wk Low:14.95
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.73
T/O Rate:85.14%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna appoints Juan Andres as COO

TIPRANKS
·
Sep 30

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

US Research Roundup-Alnylam Pharmaceuticals, Carvana, MongoDB

Reuters
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

TIPRANKS
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29

Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit

Reuters
·
Sep 29

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

TIPRANKS
·
Sep 28

EBR Systems advances FDA approval process for new WiSE manufacturing site

TIPRANKS
·
Sep 28